Problem statement:
In underserved healthcare systems worldwide, inadequate medical infrastructure leads to preventable tragedies. Manual infusion methods and disconnected monitoring systems result in dangerous medication errors, particularly for vulnerable patients requiring precise treatments like insulin therapy, chemotherapy, or postpartum care. The World Health Organisation estimates that over 50% of rural clinics in developing nations lack reliable infusion technology, contributing to thousands of avoidable deaths annually.
Our Solution:
FLUIDIX-PET represents a breakthrough in medical technology - a portable, AI-driven infusion system that combines precision drug delivery with real-time health monitoring. Our innovative device features microliter-accurate dosing that automatically adjusts to patient needs, integrated vital sign tracking (including heart rate and blood pressure), and robust 24-hour battery life with solar compatibility. Unlike conventional hospital infusion pumps, FLUIDIX-PET operates independently of electrical grids while maintaining hospital-grade accuracy, making advanced care accessible in even the most remote locations.
Impact/Potential:
FLUIDIX-PET demonstrates the potential to save approximately 58,000 lives annually in Nigeria alone by preventing medication errors. Early simulations show our solution could reduce treatment complications by 60%. The system's telehealth capabilities create new possibilities for remote patient management, which is particularly valuable in regions with healthcare worker shortages.